Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed May 7, 2026
- Accession no.
- 0001193125-26-211974
- Filed
- May 7, 2026
- Trade date
- May 6, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $153.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | American depositary share | SSaleDisposed | −8 | $151.57F3 | −$1,212.56 | 1,658 | Direct | |
| May 6, 2026 | American depositary share | SSaleDisposed | −424 | $152.67F4 | −$64,732.08 | 1,234 | Direct | |
| May 6, 2026 | American depositary share | SSaleDisposed | −128 | $153.42F5 | −$19,637.76 | 1,106 | Direct | |
| May 6, 2026 | American depositary share | SSaleDisposed | −240 | $154.41F6 | −$37,058.4 | 866 | Direct | |
| May 6, 2026 | American depositary share | SSaleDisposed | −100 | $155.97 | −$15,597 | 766 | Direct | |
| May 6, 2026 | American depositary share | SSaleDisposed | −100 | $156.00 | −$15,600 | 666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $151.17 to $151.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $152.25 to $152.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $153 to $153.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $154.02 to $154.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.